Novocure (NVCR) 2025 Earnings Outlook and Analysis
Novocure faces a pivotal year as TTFields therapy expands and reimbursement pathways evolve. This guide breaks down w...
Which Is Better For Retirement Index Fund Or Target Date Fund
We evaluate which retirement option—index fund or target date fund—fits your timeline, risk profile, and tax strategy for a smoother retirement.
26,044 articles
Uber's Gross Bookings Just Jumped: Is 2026 the Stock Moment for Uber's Growth?
A new milestone for Uber signals more than a single quarter of growth. With gross bookings up 25% and a bold autonomo...
Mercer vs IP: Paper Packaging Giants Clash in Q4 Results
Mercer International posts a brutal Q4 hit from impairment, eroding equity, while International Paper pivots to highe...
Apple Actually Benefit From Memory Shortage: A Catalyst for Growth
The global memory shortage is shaking up pricing and supply chains. This article explains how Apple can actually bene...
Where Will SoFi Technologies Be in Five Years? For Investors
As SoFi expands beyond student loan refi, the question for investors is clear: where will SoFi Technologies be in fiv...
Stellantis Stock Could Turnaround: A Realistic Path to Recovery
Stellantis has faced a painful setback, but a bold turnaround plan could spark renewed interest. This guide breaks do...
Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Why Did Intuitive Machines Stock Just Drop? Investor Guide
Intuitive Machines stock just dropped after a disappointing quarterly report. This guide breaks down what happened, w...
Says Teen’s Message Made a Difference in Autism Finances
A mother documents her autistic daughter's journey and discovers that one teen’s message made a lasting impact. The s...
Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
TransMedics Stock 104% Over: Is 2026 the Next Breakout?
TransMedics has surged 104% over the last year, catching investors’ eyes. This guide breaks down the business, the ca...
Tilray Looks Ready Breakout If One Thing Goes Right
Tilray has cleared several hurdles, but a true breakout depends on one pivotal development. This guide breaks down th...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status